This brand name is authorized in Nigeria.
The drug MISONE-N contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
5B307S63B2 - BECLOMETHASONE DIPROPIONATE
|
|
Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity. |
|
2
|
UNII
VW4H1CYW1K - MICONAZOLE NITRATE
|
|
Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. Its activity is based on the inhibition of the ergosterol biosynthesis in fungi and the change in the composition of the lipid components in the membrane, resulting in fungal cell necrosis. |
|
3
|
UNII
057Y626693 - NEOMYCIN SULFATE
|
|
Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-101024 | Cream | Misone-N Cream+++ CREAM 0.025%; 2%; 0.5% 30 g (in a tube) | Ointment in collapsible tube 16 NF-PP-347750 MISONE-N CREAM BECLOMETHASONE DIPROPIONATE BP 0.025% W/W, MICONAZOLE NITRATE BP 2% W/W, NEOMYCIN SULPHATE BP 0.5% W/W MICONAZOLE NITRATE BP 2% W/W, NEOMYCIN SULPHATE BP 0.5% W/W, BECLOMETHASONE DIPROPIONATE BP 0.025% W/W, CREAM BASE QS A4-101024 Drugs Imported Products 30g Over The Counter (OTC) 8/16/2023 TETA PHARMACEUTICALS NIG LTD, PLOT A28, MOKOLA EXTENSION, IBADAN 8023176919 tetapharm@yahoo.com CURIS LIFESCIENCES PVT LTD, PF-23, GIDC IND EST SANAND II, SANAND, AHMEDABAD, GUJARAT, INDIA, India | 25/09/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D07CC04 | Beclometasone and antibiotics | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CC Corticosteroids, potent, combinations with antibiotics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-10102, A4-101024 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.